readthroughSign in
CompanyINCYNasdaqWilmington, DE

Incyte Corporation

Incyte develops small-molecule and biologic medicines across hematology, oncology, and inflammation and autoimmunity.

10-QNov 16Latest SEC filing
Nov 16Latest story

November 2026

October 2026

September 2026

August 2026

July 2026